<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02900300</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL15_0389</org_study_id>
    <nct_id>NCT02900300</nct_id>
  </id_info>
  <brief_title>A Biobank for Diaphragm Muscular Fiber</brief_title>
  <acronym>BOTAN</acronym>
  <official_title>Constitution of a Biobank to Optimize in Vitro an Antioxydant Treatment for Diaphragm Dysfunction Induced by Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first aim of the study is to obtain from chirurgical micro biopsy myoblast in culture
      which will differentiate in Diaphragm fiber. Then these fibers will be submitted under
      mechanical stress condition similar to those imposed in vivo by mechanical ventilation to
      validate in human a model in vitro of diaphragm dysfunction induced by mechanical
      ventilation. Then the second part of the study will be to evaluate with this model, the
      efficiency of an antioxidant therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">October 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myoblast differentiation capacity</measure>
    <time_frame>24 month</time_frame>
    <description>Description: evaluation of ROS (reactive oxygen species) production by confocal microscopie of diaphragm fiber submitted in vitro by mechanical stress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myoblast proliferation capacity</measure>
    <time_frame>24 month</time_frame>
    <description>Description: Evaluation of diaphragm myoblast differenciation capacity in vitro under different concentration of antioxydant.</description>
  </secondary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Diaphragm Dysfunction</condition>
  <condition>Mechanical Ventilation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who benefeciat of a thoracotomy for local pulmonary resection in regard to a lung
        cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who will undergo a surgery for a localised broncho-pulmonary tumor (stade 1A),
             and have stopped to smoke since more than 6 month and clinically stable.

        Exclusion Criteria:

          -  Patients with neuro-muscular disorder, heart desease, chronic obtructive pulmonary
             disease, metabolic disorder or infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan MATECKI, PU-PH</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

